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Specific Regulation of the Adaptor Protein Complex
AP-3 by the Arf GAP AGAP1
-ear containing, Arf binding proteins (GGA) 1–3 (Rob-
inson and Bonifacino, 2001). By binding to and conse-
quently recruiting coat proteins to specific sites, Arf
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1Laboratory of Cellular Oncology regulates trafficking from and to the Golgi apparatus,
trans-Golgi network, and endosomes. AP-3 is an exam-Center for Cancer Research
National Cancer Institute ple of an Arf1-dependent clathrin adaptor that localizes
primarily to endosomes. This complex is composed ofBuilding 37, Room 4118
2 Cell Biology and Metabolism Branch four subunits named  (160 kDa), 3 (140 kDa), 3
(47 kDa), and 3 (23 kDa) (Dell’Angelica et al., 1997a;National Institute of Child Health and Human
Development Simpson et al., 1997). There are two isoforms of the ,
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whereas a brain-specific form contains 3B and 3BNational Institutes of Health
Bethesda, Maryland 20892 subunits (Blumstein et al., 2001). 3A and 3B are both
expressed ubiquitously. AP-3 participates in the traffick-
ing of proteins to lysosome-related organelles including
melanosomes and platelet dense granules (Kantheti etSummary
al., 1998; Dell’Angelica et al., 1999; Feng et al., 2002),
and contributes to the production of synaptic vesiclesArf1 regulates membrane trafficking at several mem-
(Faundez et al., 1998). In cells such as fibroblasts thatbrane sites by interacting with at least seven different
do not have these specialized organelles, AP-3 plays avesicle coat proteins. Here, we test the hypothesis that
role in the sorting and transport of lysosomal membraneArf1-dependent coats are independently regulated by
proteins to lysosomes (Le Borgne et al., 1998;specific interaction with Arf GAPs. We find that the Arf
Dell’Angelica et al., 1999).GAP AGAP1 directly associates with and colocalizes
The activity of Arfs is regulated by two groups ofwith AP-3, a coat protein complex involved in traffick-
proteins, namely the guanine nucleotide exchange fac-ing in the endosomal-lysosomal system. Binding is
tors (GEFs; Jackson and Casanova, 2000) and themediated by the PH domain of AGAP1 and the  and 3
GTPase activating proteins (GAPs; Donaldson and Jack-subunits of AP-3. Overexpression of AGAP1 changes
son, 2000). Fourteen Arf GEFs and 16 Arf GAPs havethe cellular distribution of AP-3, and reduced expres-
been described. The GAPs are categorized into threesion of AGAP1 renders AP-3 resistant to brefeldin A.
groups. Arf GAP1/3 belong to group 1 (Cukierman et al.,AGAP1 overexpression does not affect the distribution
1995; Liu et al., 2001), while Git1/2 compose a secondof other coat proteins, and AP-3 distribution is not
group (Premont et al., 1998; Vitale et al., 2000). The thirdaffected by overexpression of other Arf GAPs. Cells
group, the AZAPs, is structurally characterized by a coreoverexpressing AGAP1 also exhibit increased LAMP1
of PH, Arf GAP, and ANK repeat domains. Subgroupstrafficking via the plasma membrane. Taken together,
within the third group are distinguished by domains out-these results support the hypothesis that AGAP1 di-
side of the catalytic core. The prototype of this group,rectly and specifically regulates AP-3-dependent traf-
ASAP1 (Brown et al., 1998) and its closely related mem-ficking.
ber PAP (Andreev et al., 1999) contain SH3 and proline-
rich domains. ACAPs contain coiled-coil domains (Jack-Introduction
son et al., 2000). ARAP1, 2, and 3 contain a Rho-GAP
domain in addition to a sterile motif (SAM) and multipleADP ribosylation factors (Arfs) are Ras-like guanine nu-
PH domains (Miura et al., 2002; Krugmann et al., 2002).cleotide binding proteins that mediate intracellular
A subgroup, known as AGAPs (Nie et al., 2002; Xia etmembrane trafficking. The six identified mammalian Arfs
al., 2003), has a GTP binding protein-like domain (GLD)are divided into three classes. Class I includes Arf1, 2,
and a split PH domain (Figure 1A).and 3, class II includes Arf4 and 5, and class III includes
Because a single Arf isoform functions at multipleArf6 (Moss and Vaughan, 1998). Among the six Arf pro-
sites, other proteins that interact with Arf must conferteins, Arf1 and Arf6 are the best characterized. Each
the specificity of Arf function. Given that the Arf GEFsaffects both membrane and actin remodeling at multiple
and Arf GAPs outnumber the Arf proteins, a plausibleintracellular sites (Randazzo et al., 2000b).
hypothesis is that these proteins contribute to the siteThe effects of Arfs on membrane trafficking are medi-
specificity of Arf action. Here, we report that AP-3 inter-ated, at least in part, by membrane coat proteins includ-
acts with the Arf GAP AGAP1 both in vivo and in vitro.ing COPI (Rothman, 2002), the adaptor protein (AP) com-
Exogenously expressed AGAP1 colocalizes with endog-plexes 1, 3, and 4 (Boehm and Bonifacino, 2001; Le
enous AP-3. Overexpression of AGAP1 disrupts the nor-Borgne and Hoflack, 1998), and the Golgi-localized,
mal membrane association of AP-3, and trafficking to
lysosomes is also affected. These data support the hy-*Correspondence: randazzo@helix.nih.gov
pothesis that AGAP1 is a specific physiologic regulator4 Present address: Department RDR/P3 Oncology Research, AL-
TANA Pharma AG, D-78467 Konstanz, Germany. of AP-3 on endosomes.
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Figure 1. Specific Interaction between AGAP1 and AP-3
(A) Schematic of AGAP1. GLD, GTP binding protein-like domain; PH, plecksktrin homology; Arf GAP, Arf GTPase activating protein; A, ankyrin
repeat (ANK).
(B) AP-3 coimmunoprecipitated with overexpressed AGAP1. NIH 3T3 cells were transfected with an empty vector or FLAG-tagged AGAP1,
ASAP1, and ACAP1. The epitope-tagged proteins were immunoprecipitated with M2 antibody and eluted with FLAG peptide. The proteins
were resolved on a Tris-glycine gel and the epitope-tagged proteins were detected by immunoblotting with M5 antibody (top panel). The
coprecipitated AP-3 was detected with antibodies against the indicated subunits of AP-3 (bottom panels). The cell lysate was included as a
positive control.
(C) In vitro binding between AP-3 and GST fusion proteins of AGAP1. Bovine brain cytosol was incubated with GST or GST-fused AGAP1
deletion mutants at 4C overnight. Bound AP-3 was detected by immunoblot using an antibody against 3. The bovine brain cytosol was
included as a positive control.
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Results antibody to 3. AP-3 and AGAP1 were detected in the
immunoprecipitates by immunoblotting (Figure 1E).
AGAP1 was not detected in the precipitate lacking AP-3Specific Association of AGAP1 and AP-3
AGAP1 is an Arf1-specific Arf GAP involved in the endo- (Figure 1E).
cytic pathway (Nie et al., 2002). To determine the specific
site of AGAP1 action, we set out to identify proteins Structural and Functional Requirements
for Interactionassociated with AGAP1. One approach we used was to
examine immunoprecipitates of AGAP1 for coprecipi- We next determined which domains in AGAP1 mediated
the interaction of AGAP1 with AP-3. AP-3 was found totated proteins. To this end, NIH 3T3 cells were transiently
transfected with FLAG-tagged AGAP1. Proteins from associate with [R599K]AGAP1, a point mutant of AGAP1
lacking GAP activity, and wild-type AGAP1 to a similarcell lysates were immunoprecipitated with M2 anti-FLAG
gel and eluted with FLAG peptide. Silver staining of extent (Figure 1F). Thus, binding of AGAP1 to AP-3 is
independent of its GAP activity. Next, we comparedgel-resolved proteins showed a band of 140 kDa that
coprecipitated with AGAP1. The protein was recovered a series of epitope-tagged deletion mutants. Proteins
lacking the PH domain had no detectable interaction,and digested with trypsin. Tandem mass spectrometric
analysis of the tryptic peptides revealed the identity of whereas proteins containing the PH domain, including
a protein consisting of the PH domain alone, boundthe associated protein as the 3A subunit of AP-3 (see
Supplemental Data at http://www.developmentalcell. AP-3 (Figure 1F). In in vitro binding assays, GST fusion
proteins containing the PH domain bound AP-3,com/cgi/content/full/5/3/513/DC1).
Immunoblotting was used to confirm the identity of whereas GST-[GLDPH]AGAP1 did not (Figure 1C).
The results indicate the binding was mediated by thethe 3A subunit and to detect the presence of two other
subunits, 3A and 3 (A and B isoforms), of the AP-3 PH domain.
We analyzed the subunits of AP-3 involved in interac-complex in immunoprecipitates (Figure 1B). A GST-
[GLD]AGAP1 fusion protein, expressed and purified tions with AGAP1 using yeast two-hybrid and three-
hybrid systems. Initial two-hybrid assays failed to revealfrom bacteria, was incubated with a soluble lysate from
bovine brain. The fusion protein was precipitated with an interaction of AGAP1 with any single subunit of AP-3
(data not shown). Three-hybrid assays, however, dem-glutathione beads. As shown in Figure 1C, AP-3 was also
present in the precipitates, consistent with formation of onstrated an interaction of AGAP1 with a combination
of  and 3A and, less strongly,  and 3B (Figure 1G).the complex in vitro.
AGAP1 discriminated among coat proteins regulated These two subunits are known to assemble with one
another as part of the AP-3 complex (Peden et al., 2002).by Arf1. Epitope-tagged AGAP1 was immunoprecipi-
tated from NIH 3T3 fibroblast and coimmunoprecipi- The 	 subunit of AP-4 did not interact with AGAP1 (Figure
1G). Thus, interactions with AGAP1 require both  andtated proteins were detected by immunoblotting. The
signal for the 3 subunit of AP-3 was equivalent to that one of the 3 isoforms. Like other large adaptins, the 
subunit of AP-3 comprises three domains denoted trunk,for 10% of the cell lysate volume used for the immuno-
precipitation. In contrast, neither -COP, a subunit of hinge, and ear (Boehm and Bonifacino, 2001). 3 assem-
bles with the  trunk as part of the AP-3 core. AGAP1COPI, nor -adaptin, a subunit of AP-1, was detected in
the precipitate, although they were detected with similar was found to bind to a 3A- trunk dimer (Figure 1H).
signal intensity as 3 in the cell lysates (Figure 1D).
Conversely, AP-3 discriminated among GAPs. ASAP1 AGAP1 and AP-3 Colocalize
in Punctate Structuresand ACAP1, two Arf GAPs closely related to AGAP1,
were exogenously expressed to a similar level as AGAP1 The results presented above indicate that AGAP1 and
AP-3 interact in vivo. We next examined whether AGAP1in NIH 3T3 cells and immunoprecipitated in the same
manner as AGAP1. Whereas AP-3 was detected in the and AP-3 also colocalized in cells. Because no antibod-
ies good for immunofluorescence of AGAP1 are avail-precipitates containing AGAP1, none was detected with
either ASAP1 or ACAP1 (Figure 1B). Endogenous AP-3 able, we transfected cells with epitope-tagged AGAP1.
Because high levels of protein expression might affectand AGAP1 also associated with each other. AP-3 was
immunoprecipitated from bovine brain cytosol using an an AGAP1-dependent compartment, we expressed both
(D) AGAP1 specifically coimmunoprecipitated AP-3. NIH 3T3 cells were transfected with an empty vector or [FLAG]AGAP1. The immunoprecipi-
tated proteins were eluted with FLAG peptide, and immunoblot was performed to detect the FLAG-tagged AGAP1, as well as AP-3 (3), COP
I (-COP), and AP-1 (-adaptin).
(E) Association of endogenous AGAP1 and AP-3. Bovine brain cytosol was centrifuged at 100,000 
 g for 15 min at 4C. One hundred and
fifty microliters each was incubated with 10 l nonimmune sera or anti-3 at 4C overnight. The samples were then incubated with prewashed
GammaBind beads for 1 hr at 4C. The samples were washed three times and resuspended in SDS-PAGE sample buffer. Immunoprecipitated
AP-3 and AGAP1 were detected by immunoblot using antibodies against AGAP1 (top) and 3 subunit of AP-3 (bottom). Bovine brain cytosol
was also included as a positive control.
(F) PH domain of AGAP1 binds to AP-3. NIH 3T3 cells were transfected with FLAG-tagged wild-type AGAP1, a point mutant [R599K]AGAP1,
which lacks GAP activity, and the indicated deletion mutants. Immunoprecipitation and immunoblotting was performed as in (B).
(G) Interaction between AGAP1 and AP-3 subunits  and 3 in the yeast three-hybrid system.  and 	 adaptin were coexpressed with AGAP1
(1–704) and 3A or 3B adaptin, and the interaction was detected by growth on selective His and Met plates.
(H) AGAP1 interacted with full-length  and the trunk region of  subunit of AP-3 in the yeast three-hybrid system. This interaction was
dependent on the coexpression of 3A protein.
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Figure 2. AGAP1 Colocalized with AP-3 in Punctate Structures in NIH 3T3 Cells
NIH 3T3 cells were transfected with FLAG-AGAP1 (A–C) or FLAG-[R599K]AGAP1 (D–F) in pSI vectors for 24 hr. Cells were replated on
fibronectin-coated coverslips in Opti-MEM for 6 hr. The cells were fixed and stained for AP-3 (A and D), AGAP1 (B), or [R599K]AGAP1 (E).
Colocalization with AP-3 was shown in the merged micrographs for AGAP1 (C) and [R599K]AGAP1 (F). Arrows indicate colocalized AP-3 and
AGAP1 or [R599K]AGAP1. AP-3 staining in a nontransfected NIH 3T3 cell is shown in (G).
FLAG-AGAP1 and FLAG-[R599K]AGAP1 under the con- shown), did not affect the membrane association of en-
trol of the SV40 promoter. In this system, the expression dogenous AP-3 in NIH 3T3 cells. In addition, this effect
of both AGAP1 and [R599K]AGAP1 was at least 20 times of AGAP1 was specific for AP-3. While the membrane
lower than with the CMV promoter (data not shown). association of AP-3 was altered by AGAP1, the intracel-
AP-3 staining appeared as punctate structures as de- lular distribution of two other protein coats regulated by
scribed before (Figures 2A and 2G). Epitope-tagged Arf1, COPI (as detected by -COP; Figure 3B, panels a
AGAP1 also appeared in punctate structures, in many and b) and AP-1 (as detected by -adaptin; Figure 3B,
cases together with AP-3 (arrows in Figures 2A and 2B). panels c and d), was not changed by AGAP1 overexpres-
Similarly, overexpressed FLAG-[R599K]AGAP1 coloca- sion. Furthermore, this effect of AGAP1 on AP-3 was
lized with AP-3 in NIH 3T3 fibroblasts. However, the AP-3 dependent on its GAP activity. The [R599K]AGAP1 mu-
compartment was altered by expression of the mutant, tant without GAP activity did not disrupt the membrane
with AP-3 associated with larger punctate structures association of AP-3 (not shown). Therefore, inactivation
(Figure 2D), as compared to the nontransfected cells of Arf1 by AGAP1 is required to dissociate AP-3.
(Figure 2G) or wild-type AGAP1 transfected cells (Figure Overexpression of AGAP1 led to AP-3 dissociation. If
2A). These results are consistent with AGAP1 associat- this effect was due to a specific physiologic interaction
ing with and regulating the AP-3 endosomes. Similar between AGAP1 and AP-3, then reducing AGAP1 levels
results were obtained using PC6 cells (not shown). should stabilize AP-3 on membranes. To test this predic-
tion, we used siRNA to reduce AGAP1 expression (Fig-
ure 4A). In both control and siRNA-treated HeLa cells,AGAP1 Regulates the Membrane
AP-3 staining appeared as typical punctate structuresAssociation of AP-3
widely distributed throughout the cytosol, with someThe results with the [R599K] mutant of AGAP1 sug-
degree of concentration in the perinuclear region (Figuregested a possible regulatory role in the AP-3 compart-
4B, panels a and b; Figure 4B, panels e and f). Thement. To further test for this regulatory role, we exam-
cells were treated with brefeldin A (BFA) to disrupt theined the effect of overexpressing AGAP1 to high levels
function of the Arf exchange factor. With GAP function-on the cellular distribution of AP-3. To achieve high
ing normally, this treatment should reduce Arf-GTP inexpression levels, we expressed AGAP1 under the con-
the AP-3 compartment, resulting in the dissociation oftrol of the CMV promoter. As shown in Figure 2G, stain-
AP-3 from membranes. In cells with reduced GAP func-ing of AP-3 in untransfected NIH 3T3 cells appeared in
tioning in the AP-3 compartment, AP-3 should be rela-punctate loci. When AGAP1 was overexpressed, AP-3
tively resistant to BFA. As predicted, in control cells,was associated with the punctate structures to a much
AP-3 dissociated from membranes after BFA treatmentlesser extent with some diffuse distribution (Figure 3A,
for 2 min (Figure 4B, panels c and d), whereas AP-3panels a and b), suggesting dissociation of AP-3 from
remained associated with membranes after BFA treat-the membrane. This effect was specific for AGAP1. Sev-
ment when AGAP1 expression was suppressed (Figureeral other members of the AZAP family Arf GAPs, ASAP1,
ARAP1, ACAP1 (Figure 3A, panels c–h), and ACAP2 (not 4B, panels g and h). A reduction in AGAP1 did not affect
Figure 3. AGAP1 Overexpression Disrupted Membrane Association of AP-3 in NIH 3T3 Cells
(A) Panels a–h: AGAP1 disrupted AP-3 membrane association. NIH 3T3 cells were transfected with different Arf GAPs for 24 hr and the cells
were replated on fibronectin-coated coverslips in Opti-MEM for 6 hr. The cells were then fixed and stained with antibodies against AP3 and
the FLAG tag for Arf GAP.
Panels a and b: effect of AGAP1 on AP-3 distribution. The transfected cell is marked with the white box.
Panels c–j: no effect of other AZAP family members on AP-3 membrane association. Structurally related Arf GAPs such as ASAP1 (c and d),
ARAP1 (e and f), and ACAP1 (g and h) did not change cellular distribution of AP-3 after overexpression.
(B) AGAP1 did not alter the cellular distribution of COPI and AP1. NIH 3T3 cells were transfected with [FLAG]AGAP1 for 24 hr and the cells
were replated on fibronectin-coated coverslips in Opti-MEM for 6 hr. Cells were fixed and stained with antibodies against COP for COPI,
and -adaptin for AP-1. The transfected cells were stained with antibody against the epitope tag and are marked with arrows.
(C) AGAP1 increased internalization of LAMP1 antibody in HeLa cells. HeLa cells were transfected with [FLAG]AGAP1 for 24 hr and the cells
were replated on glass coverslips in DMEM containing 10% FBS for 6 hr. The monoclonal anti-LAMP1 (H4A3) or anti-FLAG (M5, as a negative
control) was incubated with the cells at 0.5 g/ml for 4 hr. The cells were then washed three times with DMEM containing 10% FBS, once
with ice-cold PBS, and fixed. The transfected cells were stained with a polyclonal antibody against FLAG tag and are marked with arrows
(panels a and d). The internalized antibodies were visualized using TRITC-conjugated goat anti-mouse secondary antibody (panels b and e).
Phase contrast images were included to visualize nontransfected cells (panels c and f).
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Figure 4. Inhibition of AGAP1 Gene Expression Conferred Resistance to BFA Treatment
(A) Immunoblot of AGAP1. HeLa cells were transfected with the siRNA without (Mock, lane 1) or with (siRNA, lane 2) oligofectamine for 3
days. The cells were harvested and cell lysates were subjected to SDS-PAGE. Endogenous AGAP1 was detected with a polyclonal antibody
(indicated by the arrow).
(B) Staining of AP-3 in HeLa cells with mock transfection (upper panel) or siRNA transfection (lower panel). The cells were treated without
(panels a, b, e, and f) and with (panels c, d, g, and h) BFA at 5 g/ml for 2 min.
(C) Staining of AP-1 in HeLa cells with mock transfection (upper panel) or siRNA transfection (lower panel). Cells were treated without (panels
a, b, e, and f) and with (panels c, d, g, and h) BFA at 5 g/ml for 2 min.
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BFA-induced dissociation of AP-1 from membranes lacks GAP activity, competes with endogenous AGAP1
for interaction with AP-3. By doing so, Arf1 function(Figure 4C, panels g and h).
and AP-3 trafficking were less effective, leading to an
accumulation of AP-3 in the putative AP-3 endosome.AGAP1 Altered AP-3-Dependent Trafficking
The interaction between AGAP1 and AP-3 is analo-of LAMP1
gous to the interaction between Arf GAP1 and coatomerAP-3 regulates the traffic of lysosomal membrane pro-
in the COPI vesicle (Eugster et al., 2000). These resultsteins being transferred to lysosomes. If the pathway is
have led us to consider whether this mechanism of site-disrupted, for instance by decreased AP-3 levels, lyso-
specific control of Arf generalizes to other coat proteinssomal membrane proteins can still reach the lysosome
and GAPs. For instance, each member of the AZAPbut are rerouted through the plasma membrane. The
family of Arf GAPs may interact with a particular coataltered pathway can be detected by incubation with
protein, such as AP-1, AP-3, and AP-4. In this way, theantibodies against the lysosomal membrane proteins
Arf GAPs might be integral components of the coatsand measuring the internalization of the antibodies (Le
(Yang et al., 2002).Borgne et al., 1998; Dell’Angelica et al., 2000). We took
We are currently investigating whether the interactionthis approach to determine whether AGAP1 affects
of AP-3 with the PH domain of AGAP1 could regulateAP-3-dependent trafficking. In HeLa cells, overexpres-
GAP activity. In ASAP1, another AZAP family member,sion of AGAP1 increased the internalization of an anti-
the PH domain N-terminal to the GAP domain is a bind-body to LAMP1. The internalization of an irrelevant anti-
ing site for phosphoinositide 4,5-bisphosphate, an allo-body, M5 monoclonal antibody, did not change (Figure
steric modulator of GAP activity (Kam et al., 2000). The3C). These data are consistent with AGAP1 disrupting
PH domain of AGAP1 appears to function in an analo-AP-3-dependent LAMP1 trafficking to lysosomes.
gous manner, with phosphoinositide binding leading to
stimulation of GAP activity. By interacting with the PHDiscussion
domain, AP-3 could either directly modify AGAP1 GAP
activity or influence activation by phospholipids.Arf1 functions together with coat proteins to regulate
In summary, we have identified an interaction betweenmembrane traffic at a number of different cellular sites.
AGAP1 and AP-3 that regulates AP-3 function on endo-The mechanisms by which Arf1 can independently regu-
somes.late the different coats at each site are not well defined.
Accessory proteins that regulate the activation and inac-
Experimental Procedurestivation of Arf have been proposed to have a role (Boni-
facino and Jackson, 2003). Here, we provide the first Plasmids and Antibodies
example, to our knowledge, of an Arf GAP that regulates The original cDNA of AGAP1 (KIAA1099) was obtained from Dr. Taka-
hiro Nagase at the Kazusa DNA Research Institute. The constructs fora specific endosomal compartment in mammalian cells.
FLAG epitope-tagged AGAP1 (amino acids 1–804), [R599K]AGAP1,Furthermore, we show that site-specific activity of the
[GLD]AGAP1 (amino acids 347–804), [GLD,PH]AGAP1 (aminoGAP is dependent on direct binding to the coat being
acids 556–804), PH (amino acids 347–535), or GLD (amino acidsregulated.
69–317), as well as their corresponding GST fusion proteins, were
The GAPs outnumber the Arfs. Localization studies obtained as previously described (Nie et al., 2002). The FLAG-AGAP1
indicate that the sites of action of various GAPs are and FLAG-[R599K]AGAP1 were also subcloned into the EcoRI and
NotI sites of pSI (Promega). The monoclonal (mAb) and polyclonalprobably different. Arf GAP1 is associated with the Golgi
anti-FLAG antibodies, as well as standard reagents, were fromapparatus, and its overexpression affects Golgi struc-
Sigma. The mAb against 3, 3, and -adaptin were from BD Biosci-ture (Huber et al., 1998), although it can also affect other
ences. Polyclonal anti-3 was described previously (Dell’Angelica etstructures when highly overexpressed (Ooi et al., 1998).
al., 1997b), and polyclonal anti-COP was from Affinity BioReagents.
ASAP1 associates with and affects the turnover of focal Monoclonal anti-LAMP1 (H4A3) was from the Developmental Stud-
adhesions (Randazzo et al., 2000a). Other Arf GAPs as- ies Hybridoma Bank developed under the auspices of the NICHD
and maintained by the Department of Biological Sciences, Universitysociate with peripheral membranous structures includ-
of Iowa, Iowa City.ing the plasma membrane (Turner et al., 2001; Matafora
et al., 2001). To our knowledge, the association of a
Cell Culture and Transfectionspecific Arf GAP with a specific endosomal compart-
NIH 3T3 (clone 7; Willumsen et al., 1991), HeLa cells, and PC6 cells
ment has not been described prior to this study. were cultured as described (Nie et al., 2002). Transfection was per-
AGAP1 affects the function of AP-3 on endosomes, formed with Lipofectamine 2000 (Invitrogen) following the manufac-
turer’s protocol. For the internalization of LAMP1 antibody, HeLaat least in part, by inactivation of Arf. As previously
cells were incubated with H4A3 or M5 at 0.5 g/ml for 4 hr. Cellsobserved using dominant-negative Arf1, the ectopic ex-
were washed three times with DMEM containing 10% FBS, oncepression of AGAP1 resulted in an altered cellular distri-
with ice-cold PBS, and fixed with 2% formaldehyde.bution of AP-3, with a loss of AP-3 associated with
large (0.5 m) punctate structures that presumably GST Fusion Protein Pull-Down Assay
represent the AP-3 endosomes. In addition, inhibition GST-fused AGAP1 and mutants were prepared as described (Nie
et al., 2002). The fusion proteins were incubated with bovine brainof AGAP1 gene expression by siRNA rendered AP-3
cytosol in a total volume of 500 l of 100 mM NaCl, 25 mM Tris HClpartly BFA resistant. The point mutant [R599K]AGAP1
(pH 8.0), 1 mM DTT, and 0.1% Triton X-100 at 4C overnight.did not induce the dissociation of AP-3 from the mem-
brane although it was able to bind AP-3. On the contrary,
Immunoprecipitation
AP-3 tended to be associated with larger size punctate Cells were harvested into lysis buffer containing 25 mM Tris-HCl
structures when [R599K]AGAP1 was overexpressed. A (pH 8.0), 100 mM NaCl, 1% Triton X-100, 10% glycerol, and protease
inhibitor cocktail (Roche). Cells were lysed with three freeze/thawplausible explanation is that [R599K]AGAP1, which
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cycles. The lysates were centrifuged at 10,000 
 g at 4C for 10 ARF1 GTPase-activating protein: zinc finger motif and Golgi com-
plex localization. Science 270, 1999–2002.min. The cleared lysates were incubated with M2 gel overnight. The
samples were briefly centrifuged and the pellet was washed three Dell’Angelica, E.C., Ohno, H., Ooi, C.E., Rabinovich, E., Roche, K.W.,
times with the lysis buffer. The FLAG-tagged proteins were then and Bonifacino, J.S. (1997a). AP-3: an adaptor-like protein complex
eluted for 30 min with FLAG peptide at 4C. For the immunoprecipita- with ubiquitous expression. EMBO J. 16, 917–928.
tion of endogenous AP-3, bovine brain cytosol was incubated with
Dell’Angelica, E.C., Ooi, C.E., and Bonifacino, J.S. (1997b). 3A-
antibody overnight at 4C. Antibody was precipitated with Gam-
adaptin, a subunit of the adaptor-like complex AP-3. J. Biol. Chem.
maBind beads (Amersham Biosciences) as described by the manu-
272, 15078–15084.
facturer.
Dell’Angelica, E.C., Shotelersuk, V., Aguilar, R.C., Gahl, W.A., and
Bonifacino, J.S. (1999). Altered trafficking of lysosomal proteins inImmunofluorescence
Hermansky-Pudlak syndrome due to mutations in the  3A subunitCells were prepared for immunofluorescence as described (Nie et
of the AP-3 adaptor. Mol. Cell 3, 11–21.al., 2002) and examined using a Zeiss Pascal confocal mounted
Dell’Angelica, E.C., Aguilar, R.C., Wolins, N., Hazelwood, S., Gahl,on an Axioplan 2 microscope equipped with 63
 and 100
 Plan-
W.A., and Bonifacino, J.S. (2000). Molecular characterization of theNeofluar oil immersion lenses or a Zeiss LSM 510 confocal mounted
protein encoded by the Hermansky-Pudlak syndrome type 1 gene.on an Axiobert 100M microscope equipped with Plan-Apochromat
J. Biol. Chem. 275, 1300–1306.63
/1.4 oil DIC and Plan neofluar 100
/1.3 oil I immersion lens (Carl
Zeiss). Donaldson, J.G., and Jackson, C.L. (2000). Regulators and effectors
of the ARF GTPases. Curr. Opin. Cell Biol. 12, 475–482.
Yeast Three-Hybrid System Eugster, A., Frigerio, G., Dale, M., and Duden, R. (2000). COPI do-
The cDNAs for 	 adaptin, full-length  adaptin, or  trunk (Boehm mains required for coatomer integrity, and novel interactions with
and Bonifacino, 2001) were subcloned into pGADT7. The cDNAs for ARF and ARF-GAP. EMBO J. 19, 3905–3917.
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